Prolonged cytopenias after immune effector cell therapy and lymphodepletion in patients with leukemia, lymphoma and solid tumors.
Anne MillerRachel DaumTao WangMengfen WuCandise TatThomas PfeifferShoba NavaiAndras HeczeyMeenakshi HegdeNabil AhmedSarah B WhittleLaQuisa HillCaridad MartinezRobert KranceCarlos A RamosRayne H RoucePremal LullaHelen E HeslopBilal OmerMeghan ShekarPublished in: Cytotherapy (2024)
Immune effector recipients often experience significant cytopenias due to marrow suppression following lymphodepletion regardless of disease, but prolonged severe cytopenias are significantly less common after treatment of patients with lymphoma and solid tumors.